Pantera

Pantera

PanTera aims to bring new hope to cancer patients by enabling the widespread use of radiopharmaceuticals for precise tumor treatment. Learn more

Launch date
Employees
Market cap
-
Enterprise valuation
CAD558—837m (Dealroom.co estimates Sep 2024.)
Mol Province of Antwerp (HQ)
  • Edit
DateInvestorsAmountRound
*

€33.8m

Debt
*

€93.0m

Series A
Total FundingCAD140m

Recent News about Pantera

Edit
More about Pantera
Edit

PanTera is a biotechnology company dedicated to advancing cancer treatment through the development and application of radiopharmaceuticals. Our mission is to bring new hope to cancer patients by enabling the widespread use of precision therapies that target and treat tumors effectively.

At PanTera, we recognize the significant potential of radiopharmaceuticals in transforming cancer care. These innovative therapies combine radioactive isotopes with targeting molecules to deliver precise, localized radiation to cancer cells, minimizing damage to healthy tissue. By harnessing the power of radiopharmaceuticals, we aim to improve treatment outcomes and enhance the quality of life for patients.

Our focus is on developing and optimizing radiopharmaceuticals that can be used in a variety of cancer types. We work closely with researchers, clinicians, and industry partners to advance the science of radiopharmaceuticals and bring these therapies to a broader range of patients. Our team of experts is committed to overcoming the technical and logistical challenges associated with the production, distribution, and administration of radiopharmaceuticals.

PanTera's approach is grounded in a deep understanding of cancer biology and the unique properties of radiopharmaceuticals. We employ advanced technologies and rigorous scientific methods to design and test new therapies, ensuring their safety and efficacy. Our goal is to create a portfolio of radiopharmaceuticals that can be tailored to the specific needs of individual patients, providing personalized and effective treatment options.

In addition to our research and development efforts, PanTera is dedicated to educating healthcare professionals and patients about the benefits of radiopharmaceuticals. We believe that increased awareness and understanding of these therapies will lead to greater adoption and improved patient access. By collaborating with key stakeholders in the healthcare community, we aim to build a supportive ecosystem for the use of radiopharmaceuticals in cancer treatment.

PanTera is driven by a passion to make a meaningful difference in the lives of cancer patients. Our commitment to innovation, scientific excellence, and patient-centered care guides our work and inspires us to push the boundaries of what is possible in cancer treatment.